000			01745cam a22002058i 4500
999			_c38369 _d38369
020			_a9789391165321
041			_aeng.
082	0	0	_a615.1 _bEBA-B
100	1		_aEban, Katherine _eauthor.
245	1	0	_aBottle of lies : _bRanbaxy and the dark side of Indian Pharma / _cKatherine Eban.
250			_aFirst edition.
260			_aNew Delhi : _bJuggernaut, _c2019.
300			_axxviii, 482p.
504			_aIncludes bibliographical references and index.
520			_aIn 2004, Dinesh Thakur, a senior employee of Ranbaxy, then India’s largest pharma company, discovered a terrible secret.Ranbaxy had been fabricating the test results of their drugs,endangering millions of patients. Thakur resigned and became a whistleblower to the US Food and Drug Administration, one of the regulators Ranbaxy had been lying to, and ultimately brought the multibillion-dollar behemoth to its knees. This is the sensational account of the high-stakes chase to bring Ranbaxy to book and the fall from grace of one of corporate India’s biggest success stories. But the rot in Indian pharma isn’t confined to Ranbaxy alone. In this book, investigative journalist Katherine Eban relies on over 20,000 FDA documents and interviews with over 240 people to show how fraud and trickery are deeply entrenched in much of the industry in India, and raises troubling questions about some of its biggest names – Wockhardt, Dr Reddy’s, Glenmark and RPG Life Sciences. Filled with shocking and eye-opening details, this book lays bare the ugly truth of Indian pharma. It will make you view every pill you take with foreboding and suspicion.
546			_aEnglish.
650		0	_aGeneric drugs _xQuality control.
650		0	_aDrug adulteration.
942			_2ddc _cBK